Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Kristiansen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 2, 2022
Statins seldom cause adverse reactionsJohn Munkhaugen, Oscar Kristiansen, Elise Sverre, et al.
British Journal of Clinical Pharmacology|September 10, 2019
A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart diseaseOscar Kristiansen, Nils T Vethe, Morten W Fagerland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 21, 2023
Frailty, health literacy and self-care in patients admitted with acute heart failureJohn Munkhaugen, Elise Sverre, Toril Dammen, et al.
European Journal of Preventive Cardiology|February 21, 2021
Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?John Munkhaugen, Elise Sverre, Kari Peersen, et al.
Pharmacology Research & Perspectives|March 27, 2025
Low-Density Lipoprotein Cholesterol Increases Significantly During Brief Discontinuation of Atorvastatin and Correlates With Metabolite Half-LivesJonas Pivoriunas, Nils Tore Vethe, Oscar Kristiansen, et al.
Therapeutic Drug Monitoring|April 28, 2022
Monitoring Simvastatin Adherence in Patients With Coronary Heart Disease: A Proof-of-Concept Study Based on Pharmacokinetic Measurements in Blood PlasmaNils Tore Vethe, Einar Husebye, Anders M Andersen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 10, 2024
Validation of a novel direct method to determine reduced adherence to atorvastatin therapyJonas Pivoriunas, Nils Tore Vethe, Einar Husebye, et al.
BMC Cardiovascular Disorders|December 17, 2021
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effectsKari Peersen, John Munkhaugen, Elise Sverre, et al.
Journal of Internal Medicine|February 1, 2022
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effectsElise Sverre, Kari Peersen, Oscar Kristiansen, et al.
Atherosclerosis|March 8, 2025
Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry dataJonas Pivoriunas, Ingrid Engebretsen, Nils Tore Vethe, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 2, 2022
Statins seldom cause adverse reactionsJohn Munkhaugen, Oscar Kristiansen, Elise Sverre, et al.
British Journal of Clinical Pharmacology|September 10, 2019
A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart diseaseOscar Kristiansen, Nils T Vethe, Morten W Fagerland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 21, 2023
Frailty, health literacy and self-care in patients admitted with acute heart failureJohn Munkhaugen, Elise Sverre, Toril Dammen, et al.
European Journal of Preventive Cardiology|February 21, 2021
Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?John Munkhaugen, Elise Sverre, Kari Peersen, et al.
Pharmacology Research & Perspectives|March 27, 2025
Low-Density Lipoprotein Cholesterol Increases Significantly During Brief Discontinuation of Atorvastatin and Correlates With Metabolite Half-LivesJonas Pivoriunas, Nils Tore Vethe, Oscar Kristiansen, et al.
Therapeutic Drug Monitoring|April 28, 2022
Monitoring Simvastatin Adherence in Patients With Coronary Heart Disease: A Proof-of-Concept Study Based on Pharmacokinetic Measurements in Blood PlasmaNils Tore Vethe, Einar Husebye, Anders M Andersen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 10, 2024
Validation of a novel direct method to determine reduced adherence to atorvastatin therapyJonas Pivoriunas, Nils Tore Vethe, Einar Husebye, et al.
BMC Cardiovascular Disorders|December 17, 2021
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effectsKari Peersen, John Munkhaugen, Elise Sverre, et al.
Journal of Internal Medicine|February 1, 2022
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effectsElise Sverre, Kari Peersen, Oscar Kristiansen, et al.
Atherosclerosis|March 8, 2025
Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry dataJonas Pivoriunas, Ingrid Engebretsen, Nils Tore Vethe, et al.
Pageof 2